<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"
                xmlns:wfw="http://wellformedweb.org/CommentAPI/"
                xmlns:dc="http://purl.org/dc/elements/1.1/"
                xmlns:sy="http://purl.org/rss/1.0/modules/syndication/">
<channel>
<title>Ambry Genetics News by Category: BRCA1 &amp; 2</title>
<link>https://blog.ambrygen.com/list/category/BRCA1%20%26%202</link>
<description>Find the latest Ambry Genetics news by category: BRCA1 &amp; 2</description>
<language>en</language>
<image>
<title>Ambry Genetics Blog</title>
<link>https://blog.ambrygen.com/list/category/BRCA1%20%26%202</link>
<url>https://blog.ambrygen.com/assets/img/logo/Ambry_logo_web.jpg</url>
</image>
<item>
<title>The CARE Difference: A Smarter Workflow for High‑Risk Screening</title>
<link>https://blog.ambrygen.com/ambry/post/431/the-care-difference-a-smarter-workflow-for-high-risk-screening</link>
<description>Danielle Rogers, oncology and genetics nurse practitioner, recently shared her experience with providing personalized assessments of cancer risks before and after implementation of the Ambry CARE Program® (CARE).</description>
<pubDate>Wed, 25 Mar 26 06:00:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Scaling Early Detection and Prevention: 5 Lessons from HCA Healthcare</title>
<link>https://blog.ambrygen.com/ambry/post/382/scaling-early-detection-and-prevention-5-lessons-from-hca-healthcare</link>
<description>Recap of a recent Becker’s Healthcare podcast with Dr. Dax Kurbegov, who shared how his team is building a scalable model for risk assessment and early detection.</description>
<pubDate>Thu, 07 Aug 25 06:52:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Personalized Care in Action: The Unexpected Discovery That Validated Our High-Risk Program</title>
<link>https://blog.ambrygen.com/ambry/post/378/personalized-care-in-action-the-unexpected-discovery-that-validated-our-high-risk-program</link>
<description>Lisa McGuire shares how a combination of innovative technology and dedicated healthcare teams can transform patient outcomes.</description>
<pubDate>Wed, 04 Jun 25 06:09:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Early Detection in Action: Angie’s CARE Story</title>
<link>https://blog.ambrygen.com/ambry/post/365/early-detection-in-action-angies-care-story</link>
<description>One CARE patient’s story demonstrates the power of proactive care and comprehensive high-risk screening.</description>
<pubDate>Thu, 31 Oct 24 05:43:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>The Evolution of Hereditary Cancer Testing: Why Pan-Cancer Panels Are the Future of Genetic Risk Assessment</title>
<link>https://blog.ambrygen.com/ambry/post/362/the-evolution-of-hereditary-cancer-testing-why-pan-cancer-panels-are-the-future-of-genetic-risk-assessment</link>
<description>Pan-cancer panels offer more comprehensive diagnoses, personalized risk assessments, and targeted prevention and treatment strategies.</description>
<pubDate>Thu, 17 Oct 24 08:18:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Expanding Your High-Risk Breast Program: Best Practices for Growth and Impact</title>
<link>https://blog.ambrygen.com/ambry/post/356/expanding-your-high-risk-breast-program-best-practices-for-growth-and-impact</link>
<description>Nurse Adrianne Alexander shares practical, engaging, and impactful best practices to expand a high-risk breast program.</description>
<pubDate>Wed, 17 Jul 24 05:36:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Putting Patients First: The Ambry CARE Program®'s Commitment to Patient Experience</title>
<link>https://blog.ambrygen.com/ambry/post/348/putting-patients-first-the-ambry-care-program-r-s-commitment-to-patient-experience</link>
<description>Heather Fecteau explains how since the launch of the Ambry CARE Program® in 2019, Ambry has also consistently helped to improve the delivery of genetic services.</description>
<pubDate>Wed, 01 May 24 07:26:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>CARE Patient Examples at Lake Health</title>
<link>https://blog.ambrygen.com/ambry/post/331/care-patient-examples-at-lake-health</link>
<description>Dr. Liese Vito shares examples of hereditary cancer testing at Lake Health for patients with a BRCA+ and PMS2 mutation and the preventative healthcare measures they were able to take.</description>
<pubDate>Wed, 07 Feb 24 03:39:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Breast Cancer Awareness Month: CHEK2 with Petra Kleiblova and Zdenek Kleibl</title>
<link>https://blog.ambrygen.com/ambry/post/321/breast-cancer-awareness-month-chek2-with-petra-kleiblova-and-zdenek-kleibl</link>
<description>Petra Kleiblova and Dr. Zdenek Kleib's commentary on ENIGMA CHEK2gether Project: A Comprehensive Study Identifies Functionally Impaired CHEK2 Germline Missense Variants Associated with Increased Breast Cancer Risk in Clinical Cancer Research journal.</description>
<pubDate>Wed, 18 Oct 23 05:24:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Ambry Spotlight: BRCAResponder Amy Byer Shainman</title>
<link>https://blog.ambrygen.com/ambry/post/320/ambry-spotlight-brcaresponder-amy-byer-shainman</link>
<description>Amy Byer Shainman, BRCAResponder, is a patient advocate, author, and producer who provides support and education related to having a pathogenic variant in BRCA1/2. Hear her thoughts on National Previvor Day and Hereditary Breast and Ovarian Cancer Week.</description>
<pubDate>Wed, 27 Sep 23 08:50:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Passing on a Legacy of Health: Ben Huebsch Shares His BRCA Story for Men’s Health Week</title>
<link>https://blog.ambrygen.com/patient/post/312/passing-on-a-legacy-of-health-ben-huebsch-shares-his-brca-story-for-mens-health-week</link>
<description>Ben Huebsch shares his firsthand experience with BRCA testing for Men’s Health Week.</description>
<pubDate>Wed, 14 Jun 23 03:00:00 -0700</pubDate>
<source>Ambry Genetics Patient Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Outlier: Runi Limary Let Her Voice Be Heard on BRCA Gene Patents</title>
<link>https://blog.ambrygen.com/ambry/post/311/outlier-runi-limary-let-her-voice-be-heard-on-brca-gene-patents</link>
<description>Runi Limary gave her testimony as a patient in the court case regarding BRCA1 and BRCA2. She shared her thoughts on the experience, her breast cancer diagnosis and observations from her work.</description>
<pubDate>Tue, 13 Jun 23 03:00:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>A Q&amp;A with My Faulty Gene founder Kathy Baker</title>
<link>https://blog.ambrygen.com/patient/post/199/a-q-a-with-my-faulty-gene-founder-kathy-baker</link>
<description>Kathy Baker, founder of My Faulty Gene, discusses the importance of genetic testing when it comes to determining hereditary cancer risk.</description>
<pubDate>Thu, 10 Nov 22 07:00:00 -0800</pubDate>
<source>Ambry Genetics Patient Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>A Different Kind of Patient: Emily Huebsch Empowers Herself and Others Against Breast Cancer</title>
<link>https://blog.ambrygen.com/patient/post/299/a-different-kind-of-patient-emily-huebsch-empowers-herself-and-others-against-breast-cancer</link>
<description>Emily is a previvor--someone who has not been diagnosed with cancer but who has tested positive for a mutation of the BRCA1 gene. She is taking control of her health to minimize her risks of developing cancer.</description>
<pubDate>Tue, 27 Sep 22 14:00:00 -0700</pubDate>
<source>Ambry Genetics Patient Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Science In 60: Looking Beyond BRCA 1/2 to Identify Women at Risk for Breast Cancer</title>
<link>https://blog.ambrygen.com/ambry/post/268/science-in-60-looking-beyond-brca-1-2-to-identify-women-at-risk-for-breast-cancer</link>
<description>Science In 60: Looking Beyond BRCA 1/ 2 to Identify Women at Risk for Breast Cancer</description>
<pubDate>Wed, 03 Oct 18 10:36:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>How my Genetic Counselor Provided Guidance When I Needed it Most</title>
<link>https://blog.ambrygen.com/patient/post/216/how-my-genetic-counselor-provided-guidance-when-i-needed-it-most</link>
<description>Without my genetic counselor and her guidance, I would have been completely lost. My primary care doctor at the time had no experience at all with the gene mutation, and could not guide me in any way.</description>
<pubDate>Thu, 28 Sep 17 18:14:00 -0700</pubDate>
<source>Ambry Genetics Patient Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>How I Lost My Lady Parts But Gained So Much More</title>
<link>https://blog.ambrygen.com/patient/post/214/how-i-lost-my-lady-parts-but-gained-so-much-more</link>
<description>My story begins more than 9 years ago, when my father called me to say was having genetic testing. His cousin had just been diagnosed with ovarian cancer and had a known BRCA mutation.</description>
<pubDate>Thu, 21 Sep 17 19:49:00 -0700</pubDate>
<source>Ambry Genetics Patient Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Do-It-Yourself Support Systems for Cancer Survivors</title>
<link>https://blog.ambrygen.com/patient/post/193/do-it-yourself-support-systems-for-cancer-survivors</link>
<description>When I was originally diagnosed with breast cancer in 2008, I sought out a multidisciplinary approach to battle my illness, after learning that outcomes tend to be more favorable when compared to following traditional approach.</description>
<pubDate>Thu, 22 Jun 17 08:10:00 -0700</pubDate>
<source>Ambry Genetics Patient Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Ambry Genetics and Leading Academic Researchers Collaborate to Improve Knowledge of Genetic Risk Factors for Breast Cancer</title>
<link>https://blog.ambrygen.com/ambry/post/7/ambry-genetics-and-leading-academic-researchers-collaborate-to-improve-knowledge-of-genetic-risk-factors-for-breast-cancer</link>
<description>Mayo Clinic and Dr. Fergus Couch collaborate with Ambry Genetics in the largest genetic study to date of women with breast cancer.</description>
<pubDate>Fri, 14 Apr 17 15:25:00 -0700</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>RNA Labs—How they Impact the Medical World</title>
<link>https://blog.ambrygen.com/ambry/post/163/rna-labs-how-they-impact-the-medical-world</link>
<description>By having the ATG Lab at Ambry, it is possible to further refine VUS results and look beyond DNA in order to determine the benign or pathogenic status of splicing.</description>
<pubDate>Thu, 02 Mar 17 23:46:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>New Research on Male Breast Cancer: Unexpected Results and Insights</title>
<link>https://blog.ambrygen.com/ambry/post/5/new-research-on-male-breast-cancer-unexpected-results-and-insights</link>
<description>Ambry Genetics, Huntsman Cancer Institute and Mayo Clinic conduct largest reported study of men with breast cancer undergoing multi-gene panel testing.</description>
<pubDate>Fri, 23 Dec 16 10:40:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Congratulations to the 2016 Battle for the Breasts Winners!</title>
<link>https://blog.ambrygen.com/ambry/post/10/congratulations-to-the-2016-battle-for-the-breasts-winners</link>
<description>The Mauli Ola Foundation has announced the winning team of their 3rd annual Battle for the Breasts (B4TB) online surf contest, as of the end of October, which was also Breast Cancer Awareness mon</description>
<pubDate>Sun, 18 Dec 16 09:35:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Dr. Fergus Couch Talks with Ambry about Recent Study Findings</title>
<link>https://blog.ambrygen.com/ambry/post/6/dr-fergus-couch-talks-with-ambry-about-recent-study-findings</link>
<description>Mayo Clinic Researcher Dr. Fergus Couch talks with Ambry about recent findings from the largest hereditary breast cancer patient study to date.</description>
<pubDate>Wed, 14 Dec 16 23:54:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Quality Genetic Testing and Why it Matters on Lifetime's 'Access Health' Television</title>
<link>https://blog.ambrygen.com/ambry/post/9/quality-genetic-testing-and-why-it-matters-on-lifetime-s-access-health-television</link>
<description>Watch Lifetime's 'Access Health' featuring Ambry Genetics CEO, Aaron Elliott, PhD, Robina Smith, MD, PhD and breast cancer survivor Christine Fenwick.</description>
<pubDate>Wed, 16 Nov 16 11:20:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
<item>
<title>Ambry Execs Discuss the Importance of Genetic Testing on Lifetime's &quot;Access Health&quot; Program</title>
<link>https://blog.ambrygen.com/ambry/post/11/ambry-execs-discuss-the-importance-of-genetic-testing-on-lifetime-s-access-health-program</link>
<description>Ambry Genetics will be featured on  &amp;quot;Access Health&amp;quot; to discuss the importance of quality genetic testing. One patient will share her personal experience.</description>
<pubDate>Mon, 07 Nov 16 11:25:00 -0800</pubDate>
<source>Ambry Genetics Ambry Blog</source>
<category>BRCA1 &amp; 2</category>
</item>
</channel>
</rss>
